Sergio L. Santillana
Overview
Sergio L. Santillana received an average of $788K in total compensation, including $291K in salary, at Merrimack Pharmaceuticals between 2017 and 2018.
Source: SEC filings on September 26, 2019 and April 27, 2018.
Related executives
We found 12 more executives who work or worked at Merrimack Pharmaceuticals.
Richard Peters
Merrimack Pharmaceuticals
Chief Executive Officer
Jean Franchi
Merrimack Pharmaceuticals
Chief Financial Officer
Jeffrey Munsie
Merrimack Pharmaceuticals
General Counsel
Gary Crocker
Merrimack Pharmaceuticals
Chairman
Daryl Drummond
Merrimack Pharmaceuticals
Head of Research
Yasir Al-Wakeel
Merrimack Pharmaceuticals
Chief Financial Officer
Robert Mulroy
Merrimack Pharmaceuticals
Chief Executive Officer
Edward Stewart
Merrimack Pharmaceuticals